REV1 and lung carcinoma: Mechanistically, the ubiquitination compound library screening system identified the USP9X deubiquitinase as a novel upstream REV1 regulatory protein, and that USP9X mediated REV1 deubiquitination modifications to stabilize its expression in lung cancer.